[Clinical evaluation of immunochemotheray on advanced gastric cancer--combination of OK-432 (picibanil), mitomycin C, and 5-fluorouracil (MF-O therapy) (author's transl)].
D001688:Biological Products / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D007167:Immunotherapy; D008937:Mitomycins / Q000008:administration & dosage*; D009367:Neoplasm Staging; D010844:Picibanil / Q000008:administration & dosage*; D013274:Stomach Neoplasms / Q000188:drug therapy*
D001688:Biological Products; D008937:Mitomycins; D010844:Picibanil; D005472:Fluorouracil